Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine plus ropivacaine soft tissue infiltration for pain after total knee arthroplasty
ChiCTR2000031063Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine and ropivacaine in postoperative pain and knee osteoarthritis (OA) (2 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoint: Total morphine consumption. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
dexmedetomidineropivacaine
03
Conditions
postoperative painknee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2000031063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031063.